DKK 5.6
(-4.44%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 12.22 Million DKK | 7.49% |
2022 | 11.37 Million DKK | 39.42% |
2021 | 8.15 Million DKK | 80.82% |
2020 | 4.51 Million DKK | 48.45% |
2019 | 3.03 Million DKK | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 1.31 Million DKK | 0.0% |
2024 Q1 | 1.31 Million DKK | -51.97% |
2023 Q4 | 2.73 Million DKK | 100.0% |
2023 Q1 | 4.74 Million DKK | -30.51% |
2023 FY | 12.22 Million DKK | 7.49% |
2023 Q3 | 1.36 Million DKK | -85.56% |
2023 Q2 | 9.48 Million DKK | 100.01% |
2022 Q4 | 6.82 Million DKK | 100.0% |
2022 FY | 11.37 Million DKK | 39.42% |
2022 Q3 | 3.41 Million DKK | -25.0% |
2022 Q2 | 4.54 Million DKK | 100.0% |
2022 Q1 | 2.27 Million DKK | 75.52% |
2021 Q1 | 2.78 Million DKK | 0.0% |
2021 FY | 8.15 Million DKK | 80.82% |
2021 Q4 | 1.29 Million DKK | 0.0% |
2021 Q3 | 1.29 Million DKK | -53.43% |
2021 Q2 | 2.78 Million DKK | -0.0% |
2020 FY | 4.51 Million DKK | 48.45% |
2019 FY | 3.03 Million DKK | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Ambu A/S | 235 Million DKK | 94.798% |
ChemoMetec A/S | 136.28 Million DKK | 91.03% |
Demant A/S | 1.79 Billion DKK | 99.319% |
GN Store Nord A/S | 228 Million DKK | 94.638% |
ViroGates A/S | -12.09 Million DKK | 201.061% |